Tango Therapeutics rebounds with a stronger pipeline, renewed focus on PRMT5 inhibitors, and key data ahead despite past ...

Vera Therapeutics stock rocketed nearly 70% on Monday on upbeat data for a kidney-disease trial. Shares are tumbling Friday ...

The HT2 trait in canola is designed to offer a more effective solution for controlling weeds resistant to commonly used herbicides. With the agricultural industry facing challenges from such resistant ...

Analysts at Truist Securities called the mid-stage data a "mixed bag," also flagging gastrointestinal adverse events. However ...

Vesting of each stock option is subject to such employee's continued service to Taysha on each vesting date. Taysha Gene Therapies (Nasdaq: TSHA) is a clinical-stage biotechnology company focused on ...

For decades, things went well for Bellevue Group. But now the sector weakness in biotechs could lead to losses.

Any point can be considered low -- even after massive gains -- provided there is plenty of upside left. That brings us to ...

Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant ...

Relative to drug developers, medical device makers have outperformed amid the turmoil of the Trump administration's healthcare reforms.

Regencell's stock soared 17,000% fueled by speculation, despite no revenue or clinical progress. Read why I think the RGC ...

Forget the hyper-volatile, high-profile stock names. In this environment, lesser-known and less-exciting stocks are apt to ...

Merck submitted a nonbinding offer for the smaller biotech earlier in the year, according to a media report citing people ...